Eisai to Acquire MGI PHARMA for $41 Per Share in an All Cash Transaction.
Business Wire › December 10, 2007
Linked as:
Extract
Eisai to Acquire MGI PHARMA for $41 Per Share in an All Cash Transaction.
TOKYO & BLOOMINGTON, Minn. -- Eisai Co., Ltd. (TSE: 4523.JP) ("Eisai"), a research-based human health care (hhc) company that focuses on neurology, gastrointestinal disorders, oncology and critical care, and MGI PHARMA, Inc. (NASDAQ: MOGN) ("MGI PHARMA"), an oncology and acute care focused biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which Eisai would acquire all of the outstanding shares of MGI PHARMA for US$41.00 per share in an all cash transaction, for a total consideration of approximately $3.9 billion.
The m...See the full content of this document
Sponsored links
